Rescue treatment of thromboembolic complications during endovascular treatment of cerebral aneurysms

Stroke

Volumn 44, Issue 5, 2013, Pages 1343-1347

  Brinjikji, Waleed ^a   McDonald, Jennifer S ^a   Kallmes, David F ^a   Cloft, Harry J ^a  

^a MAYO CLINIC   (United States)

Author keywords

endovascular treatment; interventional neuroradiology; outcomes; subarachnoid hemorrhage

Indexed keywords

ABCIXIMAB; ALTEPLASE; EPTIFIBATIDE; INTEGRILLIN; PLASMINOGEN ACTIVATOR; RETEPLASE; TENECTEPLASE; TIROFIBAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM RUPTURE; CONTROLLED STUDY; ENDOVASCULAR ANEURYSM REPAIR; FEMALE; FIBRINOLYTIC THERAPY; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THROMBOEMBOLISM; UNRUPTURED INTRACRANIAL ANEURYSM;

ADULT; AGED; AGED, 80 AND OVER; ANEURYSM, RUPTURED; DATABASES, FACTUAL; EMBOLIZATION, THERAPEUTIC; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL ANEURYSM; LENGTH OF STAY; MALE; MIDDLE AGED; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84876852036     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000628     Document Type: Article

References (19)

1. Ries T, Siemonsen S, Grzyska U, Zeumer H, Fiehler J. Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization: single center experience in 42 cases and review of the literature. Stroke. 2009;40:1750-1757.
2. Aggour M, Pierot L, Kadziolka K, Gomis P, Graftieaux JP. Abciximab treatment modalities for thromboembolic events related to aneurysm coiling. Neurosurgery. 2010;67(2 suppl operative):503-508.
3. Aviv RI, O'Neill R, Patel MC, Colquhoun IR. Abciximab in patients with ruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2005;26:1744-1750.
4. Brooks NP, Turk AS, Niemann DB, Aagaard-Kienitz B, Pulfer K, Cook T. Frequency of thromboembolic events associated with endo-vascular aneurysm treatment: retrospective case series. J Neurosurg. 2008;108:1095-1100.
5. Bruening R, Mueller-Schunk S, Morhard D, Seelos KC, Brueckmann H, Schmid-Elsaesser R, et al. Intraprocedural thrombus formation during coil placement in ruptured intracranial aneurysms: treatment with systemic application of the glycoprotein IIb/IIIa antagonist tirofban. AJNR Am J Neuroradiol. 2006;27:1326-1331.
6. Fiorella D, Albuquerque FC, Han P, McDougall CG. Strategies for the management of intraprocedural thromboembolic complications with abciximab (reopro). Neurosurgery. 2004;54:1089-1097; discussion 1097-1088
7. Gralla J, Rennie AT, Corkill RA, Lalloo ST, Molyneux A, Byrne JV, et al. Abciximab for thrombolysis during intracranial aneurysm coiling. Neuroradiology. 2008;50:1041-1047.
8. Jones RG, Davagnanam I, Colley S, West RJ, Yates DA. Abciximab for treatment of thromboembolic complications during endovascular coiling of intracranial aneurysms. AJNR Am J Neuroradiol. 2008;29:1925-1929.
9. Kang HS, Kwon BJ, Roh HG, Yoon SW, Chang HW, Kim JE, et al. Intra-arterial tirofban infusion for thromboembolism during endovascular treatment of intracranial aneurysms. Neurosurgery. 2008;63:230-237; discussion 237-238
10. Linfante I, Etezadi V, Andreone V, DeLeo M, Alehashemi S, Shaw K, et al. Intra-arterial abciximab for the treatment of thrombus formation during coil embolization of intracranial aneurysms. J Neurointerv Surg. 2010;2:135-138.
11. Mounayer C, Piotin M, Baldi S, Spelle L, Moret J. Intraarterial administration of Abciximab for thromboembolic events occurring during aneu-rysm coil placement. AJNR Am J Neuroradiol. 2003;24:2039-2043.
12. Park JH, Kim JE, Sheen SH, Jung CK, Kwon BJ, Kwon OK, et al. Intraarterial abciximab for treatment of thromboembolism during coil embolization of intracranial aneurysms: outcome and fatal hemorrhagic complications. J Neurosurg. 2008;108:450-457.
13. Song JK, Niimi Y, Fernandez PM, Brisman JL, Buciuc R, Kupersmith MJ, et al. Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab. AJNR Am J Neuroradiol. 2004;25:1147-1153.
14. Velat GJ, Burry MV, Eskioglu E, Dettorre RR, Firment CS, Mericle RA. The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surg Neurol. 2006;65:3 52-358, discussion 358.
15. Hähnel S, Schellinger PD, Gutschalk A, Geletneky K, Hartmann M, Knauth M, et al. Local intra-arterial fbrinolysis of thromboemboli occurring during neuroendovascular procedures with recombinant tissue plasminogen activator. Stroke. 2003;34:1723-1728.
16. Cognard C, Weill A, Castaings L, Rey A, Moret J. Intracranial berry aneurysms: angiographic and clinical results after endovascular treatment. Radiology. 1998;206:499-510.
17. Cronqvist M, Pierot L, Boulin A, Cognard C, Castaings L, Moret J. Local intraarterial fbrinolysis of thromboemboli occurring during endo-vascular treatment of intracerebral aneurysm: a comparison of anatomic results and clinical outcome. AJNR Am J Neuroradiol. 1998;19:157-165.
18. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosur-gical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267-1274.
19. Koebbe CJ, Horowitz MB, Levy EI, Dutton K, Jungries CC, Purdy PD. Intraarterial thrombolysis for thromboemboli associated with endo-vascular aneurysm coiling. Report of five cases. Interv Neuroradiol. 2002;8:151-158.